Doctor profile · Federal record
Dr. Matthew Trautman, PA-C
Physician Assistant · Bend, OR
- NPI 1972073260
- Accepts Medicare
- MIPS 83.8 / 100 · 2023
- 7 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2747 Ne Conners Ave
Bend, OR 977018738
(541) 382-5712
fax (541) 382-2605
Credentials & registration
- NPI registered
- November 2018 — 8 yrs on file
- Profile last updated
- November 6, 2019
- Year of graduation
- 2019 — 7 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- Oregon #PA195977
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1972073260. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
9,284
Distinct HCPCS
10
Medicare allowed
$265,614
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 3,204 | 533 | $6 | |
J7345 |
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 2,600 | 12 | $2 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 969 | 805 | $74 | |
17000 |
Destruction of precancer skin growth, 1 growth | 809 | 680 | $42 | |
17110 |
Destruction of skin growth, 1-14 growths | 416 | 370 | $94 | |
11102 |
Biopsy of related skin growth, first growth | 362 | 343 | $75 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 205 | 185 | $139 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 192 | 168 | $46 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 167 | 167 | $91 | |
96900 |
Application of ultraviolet light to skin | 104 | 27 | $20 |
In context: peer comparison
Among 60 peers in this city , average services per provider: 181. This provider delivers 51× the peer median.Open Payments
Industry payments received
All-time total
$2,630
Transactions
164
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 44 | $540.57 | |
| Lilly USA, LLC | 26 | $316.29 | |
| Janssen Biotech, Inc. | 36 | $308.73 | |
| UCB, Inc. | 6 | $291.14 | |
| Incyte Corporation | 13 | $158.65 | |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $151.20 | |
| Dermavant Sciences, Inc. | 7 | $137.87 | |
| E.R. Squibb & Sons, L.L.C. | 5 | $134.32 | |
| Novartis Pharmaceuticals Corporation | 5 | $105.95 | |
| Regeneron Healthcare Solutions, Inc. | 3 | $95.31 | |
| Organon Llc | 4 | $92.26 | |
| GENZYME CORPORATION | 4 | $77.98 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $64.65 | |
| PFIZER INC. | 2 | $35.86 | |
| Amgen Inc. | 2 | $32.45 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
553
Patients
359
Total drug cost
$20,671
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 173 | 131 | $2,476 |
| Ketoconazole | Generic | 103 | 61 | $1,768 |
| Fluorouracil | Generic | 78 | 74 | $6,826 |
| Clobetasol Propionate | Generic | 62 | 36 | $5,286 |
| Metronidazole | Generic | 34 | 0 | $1,884 |
| Clindamycin Phosphate | Generic | 30 | 0 | $1,485 |
| Doxycycline Monohydrate | Generic | 27 | 24 | $483 |
| Mupirocin | Generic | 19 | 18 | $117 |
| Hydrocortisone | Generic | 15 | 15 | $85 |
| Spironolactone | Generic | 12 | 0 | $261 |
Frequently asked questions
What is Dr. Matthew Trautman's medical specialty?
Dr. Matthew Trautman practices Physician Assistant in Bend, OR.
Where does Dr. Matthew Trautman practice?
Dr. Matthew Trautman practices at 2747 Ne Conners Ave, Bend, OR 977018738. Office phone: 5413825712.
What is Dr. Matthew Trautman's NPI?
Dr. Matthew Trautman's National Provider Identifier (NPI) is 1972073260, issued by NPPES.
Does Dr. Matthew Trautman accept Medicare assignment?
Yes. Dr. Matthew Trautman accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Matthew Trautman commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.